Topical Activatable Fluorescence Probes for Rapid Intraoperative Detection of Peritoneal Dissemination in High-Grade Serous Ovarian Carcinoma
Hanae SekineiD, Kyohhei FujitaiD, Emiko YoshidaiD, Tasuku UenoiD, Toru KomatsuiD, Takuo HayashiiD, Daiki OgishimaiD, Yusen SugimuraiD, Yasuteru UranoiD, Yasuhisa TeraoiD
Abstract
BackgroundEpithelial ovarian cancer (EOC) is one of the most lethal gynecologic malignancies, largely because most patients are diagnosed at an advanced stage with peritoneal dissemination. High-grade serous carcinoma (HGSC), the most common and aggressive EOC subtype, requires complete cytoreductive surgery to improve the prognosis; however, minute disseminated lesions are often missed by conventional intraoperative inspection. Here, we aimed to develop fluorescence probes for rapid and sensitive intraoperative detection of HGSC peritoneal dissemination. MethodsWe screened a hydroxymethyl rhodamine green (HMRG)-based fluorescence probe library consisting of 381 protease- and aminopeptidase-reactive fluorescence probes using tumor and non-tumor specimens from patients with HGSC. The target enzyme of the hit probes was identified by means of enzyme assays, immunohistochemistry, and LC/MS analysis. Diagnostic utility was evaluated ex vivo using clinical specimens and in vivo using a peritoneal dissemination mouse model. ResultsThree probes--EK-HMRG, NA-HMRG and DA-HMRG--were selected as promising candidates for the detection of peritoneal dissemination in HGSC. Puromycin-sensitive aminopeptidase (PSA) was identified as a novel target enzyme of these probes. EK-HMRG, NA-HMRG and DA-HMRG rapidly detected peritoneal dissemination just a few millimeters in size with high sensitivity and specificity in clinical HGSC specimens and in a peritoneal dissemination mouse model after topical application. ConclusionsThe PSA-targeting topical fluorescence probes EK-HMRG, NA-HMRG and DA-HMRG are promising tools for real-time, highly sensitive intraoperative visualization of peritoneal dissemination in HGSC, and are promising candidates to improve complete resection rates.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Preneoplastic lesions fimbria pan-proteomic studies establish the fimbriectomy benefit for BRCA1/2 patients and identify early diagnosis markers of HGSC
M. Wisztorski, P. saudemont, … M. Salzet·bioRxiv·Oct 4, 2020
- Both Fallopian Tube and Ovarian Surface Epithelium Can Act as Cell-of-Origin for High Grade Serous Ovarian Carcinoma
B. G. Neel, S. Zhang, … D. A. Levine·bioRxiv·Nov 29, 2018
- Profiling extracellular vesicles in circulation enables the early detection of ovarian cancer
H. Lee, D. M. Dinulescu, … B. R. Reuda·bioRxiv·Jan 19, 2023
- Effects of a novel proteasome inhibitor, UR238 on the tumor immune microenvironment and growth in epithelial ovarian cancer
J. Miller, Naixin Zhang, … Rachael B. Rowswell-Turner·bioRxiv·Nov 21, 2025
- A cell-of-origin epigenetic tracer reveals clinically distinct subtypes of high grade serous ovarian cancer
P. Lo Riso, C. E. Villa, … G. Testa·bioRxiv·Nov 30, 2018
- Targeted Proteomics of Plasma Extracellular Vesicles Uncovers MUC1 as Combinatorial Biomarker for the Early Detection of High-grade Serous Ovarian Cancer
T. T. Cooper, D. Z. Dieters-Castator, … L. M. Postovit·bioRxiv·Mar 31, 2022